Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Stocks
RPG Life Sciences Ltd.
Swot
RPG Life Sciences Ltd. SWOT Analysis: Strengths, Weakness, Opportunity, and Threats
RPG Life Sciences Ltd. has 29 Strengths, 4 Weaknesses, 2 Opportunities and 0 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential
Add SWOT widget to your site/app
Strengths
(29)
Weakness
(4)
Opportunity
(2)
Threats
(0)
Others
(2)
Companies with no Debt
Benjamin Graham Value Screen
30 Day SMA crossing over 200 Day SMA, and current price greater than open
Companies with current TTM PE Ratio less than 3 Year, 5 Year and 10 Year PE
Companies with 10% increase in share price over three months, with rising net profit growth
Strong Momentum: Price above short, medium and long term moving averages
Consistent Highest Return Stocks over Five Years
Mid-range Performer (DVM)
Stocks with Consistent Share Price Growth (subscription)
Relative Outperformance versus Industry over 1 Month
Relative Outperformance versus Industry over 1 Year
Companies with high TTM EPS Growth
Strong QoQ EPS Growth in recent results
Annual Profit Growth higher than Sector Profit Growth
PEG lower than Industry PEG
Dividend yield greater than sector dividend yield
High Momentum Scores (Technical Scores greater than 50)
Relative Outperformance versus Industry over 1 Month
Effectively using Shareholders fund - Return on equity (ROE) improving since last 2 year
Efficient in managing Assets to generate Profits - ROA improving since last 2 year
Growth in Net Profit with increasing Profit Margin (QoQ)
Growth in Quarterly Net Profit with increasing Profit Margin (YoY)
Increasing profits every quarter for the past 2 quarters
Company able to generate Net Cash - Improving Net Cash Flow for last 2 years
Annual Net Profits improving for last 2 years
Book Value per share Improving for last 2 years
Companies with Zero Promoter Pledge
RSI indicating price strength
Stocks Outperforming their Industry Price Change in the Quarter
MACD Crossover Below Signal Line
Increasing Trend in Non-Core Income
MACD crossed below signal line previous end of day
Top Losers
FII / FPI or Institutions increasing their shareholding
MFs increased their shareholding last quarter
Average Affordability - Stocks with Medium Trendlyne Valuation Score versus Benchmarks
Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks
